← FDA Drug Approvals (Drugs@FDA)

BETAMETHASONE VALERATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2023-04-18

Drug application

FDA Application #

ANDA210639

Application type

Abbreviated New Drug Application (Generic)

Brand name

BETAMETHASONE VALERATE

Generic name

BETAMETHASONE VALERATE FOAM

Active ingredients

BETAMETHASONE VALERATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Xiromed, LLC.

First approval

2023-04-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown